James L Weese (James Weese)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Oxide Nanoparticles

Top Venues

Cancer research communications

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Qi Liu, Chenan Zhang, Yue Huang, Ruihao Huang, Shiew Mei Huang, Erin Larkins, Liza Stapleford, Donna R Rivera, Paul G Kluetz, Shenggang Wang, Hao Zhu, James L Weese, Elizabeth Cromartie, Mahder Teka, Sheetal Walters, Frank M Wolf, Thomas D Brown
Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data. Cancer research communications 3 (2) (2023)
Qi Liu, Chenan Zhang, Yue Huang, Ruihao Huang, Shiew Mei Huang, Erin Larkins, Liza Stapleford, Donna R Rivera, Paul G Kluetz, Shenggang Wang, Hao Zhu, James L Weese, Elizabeth Cromartie, Mahder Teka, Sheetal Walters, Frank M Wolf, Thomas D Brown
Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data. Cancer research communications 3 (2) (2023)
Mary K Walters, Andrew T Ackerman, James L Weese, Antony Ruggeri, Michael P Mullane, Alicia Hunt, Amanda Wilson, Brenda L Ramczyk, Michael A Thompson
Quantifying the Value of the Molecular Tumor Board: Discordance Recommendation Rate and Drug Cost Avoidance. JCO precision oncology 6 (2022)